Difference between revisions of "Template:Antiarrhythmic agents"
Jump to navigation
Jump to search
blackwiki>TonyTheTiger (adding {{collapsible option}} and/or {{{state}}}) |
blackwiki>Vaccinationist |
||
| Line 16: | Line 16: | ||
| group1 = class Ia ([[Cardiac action potential#Phase 0|Phase 0]]→ and [[Cardiac action potential#Phase 3|Phase 3]]→) | | group1 = class Ia ([[Cardiac action potential#Phase 0|Phase 0]]→ and [[Cardiac action potential#Phase 3|Phase 3]]→) | ||
| list1 = | | list1 = | ||
| − | |||
| − | |||
* [[Ajmaline]] | * [[Ajmaline]] | ||
* [[Disopyramide]] | * [[Disopyramide]] | ||
| + | * [[Lorajmine]] | ||
* [[Prajmaline]] | * [[Prajmaline]] | ||
| − | * [[ | + | * [[Procainamide]]<sup>#</sup> |
| + | * [[Quinidine]]<sup>#</sup> | ||
* [[Sparteine]] | * [[Sparteine]] | ||
| group2 = class Ib ([[Cardiac action potential#Phase 3|Phase 3]]←) | | group2 = class Ib ([[Cardiac action potential#Phase 3|Phase 3]]←) | ||
| list2 = | | list2 = | ||
| − | * ''[[Intravenous therapy|IV]]'' ([[Lidocaine]] | + | * ''[[Intravenous therapy|IV]]'' ([[Lidocaine]]<sup>#</sup>) |
| − | * ''[[enteral]]'' ([[ | + | * ''[[enteral]]'' ([[Aprindine]] |
| − | * [[ | + | * [[Mexiletine]] |
| − | * [[ | + | * [[Tocainide]]) |
| group3 = class Ic ([[Cardiac action potential#Phase 0|Phase 0]]→) | | group3 = class Ic ([[Cardiac action potential#Phase 0|Phase 0]]→) | ||
| list3 = | | list3 = | ||
| − | * [[Encainide]]‡ | + | * [[Encainide]]<sup>‡</sup> |
* [[Flecainide]] | * [[Flecainide]] | ||
| + | * [[Indecainide]]<sup>‡</sup> | ||
* [[Lorcainide]] | * [[Lorcainide]] | ||
| − | * [[Moracizine]]‡ | + | * [[Moracizine]]<sup>‡</sup> |
* [[Propafenone]] | * [[Propafenone]] | ||
| Line 44: | Line 45: | ||
| list3 = | | list3 = | ||
* [[Amiodarone]] | * [[Amiodarone]] | ||
| − | |||
* [[Bretylium]] | * [[Bretylium]] | ||
* [[Bunaftine]] | * [[Bunaftine]] | ||
* [[Dofetilide]] | * [[Dofetilide]] | ||
| + | * [[Dronedarone]] | ||
| + | * [[E-4031]]<sup>†</sup> | ||
* [[Ibutilide]] | * [[Ibutilide]] | ||
* [[Nifekalant]] | * [[Nifekalant]] | ||
| Line 53: | Line 55: | ||
* [[Tedisamil]] | * [[Tedisamil]] | ||
* [[Vernakalant]] | * [[Vernakalant]] | ||
| − | |||
| group4 = [[Antiarrhythmic agent#Class IV agents|class IV]]<br/>([[Cardiac action potential#Phase 4|Phase 4]]→, [[calcium channel blocker|Ca<sup>2+</sup> channel blockers]]) | | group4 = [[Antiarrhythmic agent#Class IV agents|class IV]]<br/>([[Cardiac action potential#Phase 4|Phase 4]]→, [[calcium channel blocker|Ca<sup>2+</sup> channel blockers]]) | ||
| list4 = | | list4 = | ||
| − | |||
* [[Diltiazem]] | * [[Diltiazem]] | ||
| + | * [[Verapamil]]<sup>#</sup> | ||
}} | }} | ||
| Line 68: | Line 69: | ||
| group2 = [[Antiarrhythmic agent#Class II agents|class II]]<br/>([[Cardiac action potential#Phase 4|Phase 4]]→, [[beta blocker|β blocker]]s) | | group2 = [[Antiarrhythmic agent#Class II agents|class II]]<br/>([[Cardiac action potential#Phase 4|Phase 4]]→, [[beta blocker|β blocker]]s) | ||
| list2 = | | list2 = | ||
| − | |||
* [[Nadolol]] | * [[Nadolol]] | ||
* [[Pindolol]] | * [[Pindolol]] | ||
| − | * ''cardioselective'' ([[ | + | * [[Propranolol]] |
| − | * [[ | + | * ''cardioselective'' ([[Acebutolol]] |
| − | * [[ | + | * [[Atenolol]] |
| − | * [[ | + | * [[Esmolol]] |
| + | * [[Metoprolol]]) | ||
| − | | group5 = [[adenosine A1 receptor| | + | | group5 = [[adenosine A1 receptor|A<sub>1</sub> agonist]] |
| list5 = | | list5 = | ||
* [[Adenosine]] | * [[Adenosine]] | ||
| − | | group6 = [[Muscarinic acetylcholine receptor M2| | + | | group6 = [[Muscarinic acetylcholine receptor M2|M<sub>2</sub>]] |
| list6 = | | list6 = | ||
* [[muscarinic antagonist]]: [[Atropine]] | * [[muscarinic antagonist]]: [[Atropine]] | ||
| − | * [[ | + | * [[Disopyramide]] |
| − | * [[ | + | * [[Quinidine]]<BR>[[muscarinic agonist]]: [[Digoxin]] |
| group7 = [[Adrenergic receptor#.CE.B1 receptors|α receptors]] | | group7 = [[Adrenergic receptor#.CE.B1 receptors|α receptors]] | ||
| list7 = | | list7 = | ||
| + | * [[Amiodarone]] | ||
| + | * [[Bretylium]] | ||
* [[Quinidine]] | * [[Quinidine]] | ||
* [[Verapamil]] | * [[Verapamil]] | ||
| − | |||
| − | |||
}} | }} | ||
Revision as of 13:24, 30 August 2013
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state= parameter may be used:
|state=collapsed:{{Antiarrhythmic agents|state=collapsed}}to show the template collapsed, i.e., hidden apart from its title bar|state=expanded:{{Antiarrhythmic agents|state=expanded}}to show the template expanded, i.e., fully visible|state=autocollapse:{{Antiarrhythmic agents|state=autocollapse}}
If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.